AZD1390

CAS : 2089288-03-7

Ref. 3D-PID28803

Informations sur le produit

• Nom: AZD1390
• CAS: 2089288-03-7

Description

AZD1390 is a positron-emitting drug that can be used to study the molecular mechanisms of cancer. It binds to receptors on the surface of cells, activating cell signaling pathways, and is currently being studied for use in the treatment of squamous carcinoma. AZD1390 is able to penetrate solid tumours and it has been found to be effective against some types of cancer. The clinical studies showed that AZD1390 was safe and well-tolerated in patients with advanced cancers and that it had an acceptable side effect profile. This drug also has pharmacokinetic properties which make it suitable as a therapeutic agent.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 477.57 g/mol
• Formule: C₂₇H₃₂FN₅O₂
• Degré de pureté: Min. 95%